The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Safra Campus at Givat Ram, Jerusalem 91904, Israel.
Haematologica. 2012 May;97(5):670-8. doi: 10.3324/haematol.2011.054858. Epub 2011 Dec 16.
In transfusional siderosis, the iron binding capacity of plasma transferrin is often surpassed, with concomitant generation of non-transferrin-bound iron. Although implicated in tissue siderosis, non-transferrin-bound iron modes of cell ingress remain undefined, largely because of its variable composition and association with macromolecules. Using fluorescent tracing of labile iron in endosomal vesicles and cytosol, we examined the hypothesis that non-transferrin-bound iron fractions detected in iron overloaded patients enter cells via bulk endocytosis.
Fluorescence microscopy and flow cytometry served as analytical tools for tracing non-transferrin-bound iron entry into endosomes with the redox-reactive macromolecular probe Oxyburst-Green and into the cytosol with cell-laden calcein green and calcein blue. Non-transferrin-bound iron-containing media were from sera of polytransfused thalassemia major patients and model iron substances detected in thalassemia major sera; cell models were cultured macrophages, and cardiac myoblasts and myocytes.
Exposure of cells to ferric citrate together with albumin, or to non-transferrin-bound iron-containing sera from thalassemia major patients caused an increase in labile iron content of endosomes and cytosol in macrophages and cardiac cells. This increase was more striking in macrophages, but in both cell types was largely reduced by co-exposure to non-transferrin-bound iron-containing media with non-penetrating iron chelators or apo-transferrin, or by treatment with inhibitors of endocytosis. Endosomal iron accumulation traced with calcein-green was proportional to input non-transferrin-bound iron levels (r(2) = 0.61) and also preventable by pre-chelation.
Our studies indicate that macromolecule-associated non-transferrin-bound iron can initially gain access into various cells via endocytic pathways, followed by iron translocation to the cytosol. Endocytic uptake of plasma non-transferrin-bound iron is a possible mechanism that can contribute to iron loading of cell types engaged in bulk/adsorptive endocytosis, highlighting the importance of its prevention by iron chelation.
在输血性血色素沉着症中,血浆转铁蛋白的铁结合能力经常被超越,同时产生非转铁蛋白结合铁。尽管非转铁蛋白结合铁与组织铁沉着有关,但细胞内侵的方式仍未定义,主要是因为其组成可变且与大分子结合。我们使用荧光示踪法追踪内体小泡和细胞质中不稳定的铁,以检验这样一个假设:在铁过载患者中检测到的非转铁蛋白结合铁通过批量内吞作用进入细胞。
荧光显微镜和流式细胞术作为分析工具,用于追踪氧化反应性大分子探针 Oxyburst-Green 进入内体的非转铁蛋白结合铁进入以及用细胞负载的 calcein green 和 calcein blue 进入细胞质。非转铁蛋白结合铁的培养基来自于输血过多的地中海贫血患者的血清和地中海贫血患者血清中检测到的模型铁物质;细胞模型是培养的巨噬细胞、心肌成肌细胞和心肌细胞。
将细胞暴露于柠檬酸铁与白蛋白一起,或与地中海贫血患者的非转铁蛋白结合铁血清一起,导致巨噬细胞和心肌细胞的内体和细胞质中不稳定铁含量增加。在巨噬细胞中,这种增加更为明显,但在这两种细胞类型中,通过与非穿透性铁螯合剂或脱铁转铁蛋白共同暴露于含有非转铁蛋白结合铁的培养基中,或通过用内吞作用抑制剂处理,这种增加大部分被减少。用 calcein-green 追踪的内体铁积累与输入的非转铁蛋白结合铁水平成正比(r²=0.61),并且可以通过预先螯合来预防。
我们的研究表明,与大分子结合的非转铁蛋白结合铁最初可以通过内吞途径进入各种细胞,然后铁转移到细胞质。血浆非转铁蛋白结合铁的内吞摄取是一种可能的机制,可以导致参与批量/吸附性内吞作用的细胞类型的铁负荷增加,这凸显了通过铁螯合来预防其发生的重要性。